ArticleCancer medicine2026

Rechallenge With Immunotherapy for ES-SCLC: Efficacy and Safety From a Retrospective Propensity Score-Matched Study.

Yuxia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.